BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 15598698)

  • 1. Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients.
    Ciampelli M; Leoni F; Cucinelli F; Mancuso S; Panunzi S; De Gaetano A; Lanzone A
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1398-406. PubMed ID: 15598698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of insulin resistance in lean women with polycystic ovary syndrome.
    Morciano A; Romani F; Sagnella F; Scarinci E; Palla C; Moro F; Tropea A; Policola C; Della Casa S; Guido M; Lanzone A; Apa R
    Fertil Steril; 2014 Jul; 102(1):250-256.e3. PubMed ID: 24825420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.
    Legro RS; Finegood D; Dunaif A
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2694-8. PubMed ID: 9709933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
    Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
    Legro RS; Castracane VD; Kauffman RP
    Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of abnormal glucose metabolism in women with polycystic ovary syndrome.
    Möhlig M; Spranger J; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Moltz L; Brabant G; Schöfl C
    Eur J Endocrinol; 2006 Feb; 154(2):295-301. PubMed ID: 16452544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
    Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
    Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states.
    Rabasa-Lhoret R; Bastard JP; Jan V; Ducluzeau PH; Andreelli F; Guebre F; Bruzeau J; Louche-Pellissier C; MaItrepierre C; Peyrat J; Chagné J; Vidal H; Laville M
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4917-23. PubMed ID: 14557474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Critical evaluation of the oral glucose tolerance test for the diagnosis of insulin resistance in patients with polycystic ovary syndrome].
    Calvar CE; Bengolea SV; Hermes R; Loyato M
    Medicina (B Aires); 2007; 67(1):1-7. PubMed ID: 17408014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agreement among insulin sensitivity indexes on the diagnosis of insulin resistance in polycystic ovary syndrome and ovulatory women.
    de Paula Martins W; Santana LF; Nastri CO; Ferriani FA; de Sa MF; Dos Reis RM
    Eur J Obstet Gynecol Reprod Biol; 2007 Aug; 133(2):203-7. PubMed ID: 17207902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes.
    Tosi F; Bonora E; Moghetti P
    Hum Reprod; 2017 Dec; 32(12):2515-2521. PubMed ID: 29040529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The quantitative insulin sensitivity check index is not able to detect early metabolic alterations in young patients with polycystic ovarian syndrome.
    Angioni S; Sanna S; Magnini R; Melis GB; Fulghesu AM
    Gynecol Endocrinol; 2011 Jul; 27(7):468-74. PubMed ID: 20540677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using simple clinical measures to predict insulin resistance or hyperglycemia in girls with polycystic ovarian syndrome.
    Cree-Green M; Cai N; Thurston JE; Coe GV; Newnes L; Garcia-Reyes Y; Baumgartner AD; Pyle L; Nadeau KJ
    Pediatr Diabetes; 2018 Dec; 19(8):1370-1378. PubMed ID: 30246333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring insulin sensitivity in postmenopausal women covering a range of glucose tolerance: comparison of indices derived from the oral glucose tolerance test with the euglycemic-hyperinsulinemic clamp.
    Piché ME; Lemieux S; Corneau L; Nadeau A; Bergeron J; Weisnagel SJ
    Metabolism; 2007 Sep; 56(9):1159-66. PubMed ID: 17697856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of HOMA IR with the minimal model for measuring insulin sensitivity in polycystic ovary syndrome].
    Amador N; Espinoza G; Guízar JM; González M; Alpízar M
    Rev Invest Clin; 2001; 53(5):407-12. PubMed ID: 11795106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
    Svendsen PF; Nilas L; Madsbad S; Holst JJ
    Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.